DISCOVERY AND CHARACTERIZATION OF OLIGONUCLEOTIDE THERAPEUTICS

55:48
Therapeutic Oligonucleotide Discovery & Development: Development Day 2

54:11
Shalini Andersson: Developing Oligonucleotides Into Therapies

1:00:48
WEBINAR | Enhancing LC-MS analysis of oligos, peptides, and glycans using hybrid surface technology

48:28
Integrated Solutions & Research Strategies for the Discovery of Targeted Protein Degraders

58:15
Multi-organ-on-chip model for improving drug safety during pregnancy

1:02:45
Nucleic Acid Therapeutics: Successes, Milestones, and Upcoming Innovation

8:13
Defining mCRPC Versus mCSPC: Hormonal Sensitivity, Resistance, and the Role of Testosterone

18:43